Convertible nephroureteral catheter

Information

  • Patent Grant
  • 11439493
  • Patent Number
    11,439,493
  • Date Filed
    Friday, April 20, 2018
    6 years ago
  • Date Issued
    Tuesday, September 13, 2022
    a year ago
Abstract
A nephroureteral catheter is provided that comprises a detachable portion such that when the detachable portion is removed, the catheter converts into an internal stent. The catheter includes a tube with two retention features, a detachable portion, and an inner tube. The inner tube is removably insertable into both the tube and the detachable portion, and a wire extends through at least a portion of a lumen of the inner tube and through the tube, to keep the pieces attached. The wire may be removed to remove the inner tube and then the detachable portion from the tube. When the detachable portion is attached to the tube, the catheter is a nephroureteral catheter. When the detachable portion is removed from the tube, the catheter becomes a stent.
Description
BACKGROUND

Field


The present invention relates generally to catheters. More particularly, the present invention relates to a nephroureteral catheter.


Many patients experience the development of a stricture or blockage within the ureter of one or both kidneys. The ureter is the muscular tube that connects the kidney to the bladder. As urine is made by the kidney it drains into a central collecting system of the kidney and then travels though the ureter into the bladder. Patients can develop strictures, or blockages, of the ureter due to kidney stones, cancers, infections, trauma, and prior medical instrumentations. In rare instances, some children are born with blockages of one or both ureters. If untreated, the blockage will eventually lead to kidney failure.


Regardless the cause, the treatment for a blocked ureter is to relieve the blockage. Blockage removal is performed by inserting a long tube to connect the collecting system of the kidney to the bladder. This tube is called a stent and is placed through the ureter.


Stent insertion is typically performed by one of two methods. The stent may be inserted urologically. With this method, a scope is advanced through the urethra into the bladder. A wire is then inserted into the ureter in a retrograde fashion, using the scope to thread the wire. When the wire reaches the collecting system of the kidney, a plastic stent is inserted over the wire. The stent is a straight plastic tube that has a pigtail-shaped curl on each end. Once in place, the wire is removed and the scope is taken out of the bladder. One pigtail curl of the stent resides in the collecting system of the kidney and the other resides in the bladder. The straight portion of the stent traverses the ureter. This is performed using direct visualization with the scope and also with fluoroscopic guidance. The stent usually stays in for a period of approximately three months, at which point the stent is then swapped out for a new stent by the urologist using a similar technique.


The second method for insertion is to insert the stent percutaneously. This method is typically performed in stages. The right or left flank of the patient is sterilely prepared depending upon which kidney is to be accessed (sometimes both are accessed to treat bilateral blockages). Intravenous sedation is used. A small bore needle is used to puncture the collecting system of the kidney and contrast is injected allowing the complete visualization of the entire collecting system. The central portion is initially punctured with a small needle, and then a larger needle is used to puncture a smaller but safer area of the collecting system. A guidewire is threaded into the collecting system of the kidney and a pigtail drain, or nephrostomy catheter, is placed, sutured to the back, and hooked up to a bag for external drainage. Once the urine has cleared from bleeding, the patient is brought back to the angiography table, placed prone, and a wire is inserted through the catheter into the kidney. The catheter is then removed. The wire is threaded through the ureter into the bladder (across the stricture) and a nephroureteral catheter is placed.


A nephroureteral catheter is a long plastic tube that goes from the outside of the patient into the kidney's collecting system, through the ureter, and into the bladder. The catheter allows drainage of urine into the bladder and externally into a bag. The catheter typically stays in the patient for 7-10 days, at which time the patient is brought back to the angiography table and a wire is threaded through this tube into the bladder. The tube is removed and an internal stent is placed using fluoroscopic guidance. This is the same type of stent that is placed by the urologist working through the bladder. This can be a complex and difficult procedure.


SUMMARY

In accordance with the present invention, a nephroureteral catheter is provided that comprises a detachable portion such that when the detachable portion is removed, the catheter converts into an internal stent.


The catheter includes a tube having a circular cross section, a first end, a second end, a first retention feature near the first end, and a second retention feature near the second end. The catheter also comprises a detachable portion, wherein the detachable portion is in fluid communication with and is removably attachable to the tube at the second end, an inner tube comprising at least one lumen, wherein the inner tube is removably insertable into both the tube and the detachable portion, and a wire extending through at least a portion of a lumen of the at least one lumen of the inner tube. A portion of the wire is attached to the tube.


The convertible nephroureteral catheter eliminates the step of removing a nephroureteral catheter and placing a new internal stent into a patient. Because a step is eliminated, the convertible nephroureteral catheter saves time. Instead of a physician having to take steps such as sterile prep to place a new catheter inside a patient, the physician need only unlock the hub of the convertible nephroureteral catheter to detach the external portion of the catheter. Money is also saved since one less catheter will be required. In addition, other supplies such as wires, sheaths, and other equipment needed to place a typical internal catheter will be spared. The patient will only be subjected to minimal, if any, radiation from fluoroscopy.


The convertible nephroureteral catheter will also result in less patient discomfort, again due to minimal manipulation because less steps are required. With previous stent insertion procedures, local and IV sedation and nursing monitoring were required.


Patients will not require sedation for the process of removing the removable portion of the convertible nephroureteral catheter. The new procedure for transforming the convertible nephroureteral catheter may be performed at bedside.


The convertible nephroureteral catheter allows for the catheter insertion process to be a single step instead of a multiple-step process. The ability to insert a catheter percutaneously with a single step might provide an advantage over urological insertion, as they will both now require only a single step for insertion, yet using the convertible nephroureteral catheter will not require the general anesthesia required by urological insertion.





BRIEF DESCRIPTION OF THE DRAWINGS

Various embodiments are described herein with reference to the following drawings. Certain aspects of the drawings are depicted in a simplified way for reason of clarity. Not all alternatives and options are shown in the drawings and, therefore, the invention is not limited in scope to the content of the drawings. In the drawings:



FIG. 1 depicts a nephroureteral catheter, in accordance with example embodiments;



FIG. 2 depicts a detachable portion of the nephroureteral catheter of FIG. 1, in accordance with example embodiments;



FIG. 3 depicts a detachable portion of the nephroureteral catheter of FIG. 1, in accordance with example embodiments;



FIG. 4a depicts a detailed view of a removable attachment system, in accordance with example embodiments;



FIG. 4b depicts a detailed view of a removable attachment system, in accordance with example embodiments;



FIGS. 5a-5b depict detailed views of a removable attachment system, in accordance with example embodiments;



FIG. 6 depicts a detailed view of a removable attachment system, in accordance with example embodiments;



FIG. 7 depicts a detailed view of a removable attachment system, in accordance with example embodiments; and



FIG. 8 depicts a stent that remains after a detachable portion has been removed, in accordance with example embodiments.





DETAILED DESCRIPTION


FIG. 1 depicts a catheter 100, in accordance with example embodiments. Catheter 100 is provided for use as a nephroureteral catheter and is configured to be placed within a patient.


Catheter 100 allows for the drainage of urine into the bladder and externally into a bag. Catheter 100 includes a tube 110 having a circular cross section 120, a detachable portion 130, a locking mechanism 140, an inner tube 150, a first pigtail curl 160, a second pigtail curl 170, and a marker 190. Catheter 100 also includes a first end 112, a second end 114, and a plurality of holes 116. When detachable portion 130 is attached to the catheter, catheter 100 is a nephroureteral catheter. When detachable portion 130 is removed from the catheter, the catheter becomes a stent 200, as shown in FIG. 8.


Tube 110 may be flexible. The tube 110 has a hollow interior or lumen to allow for fluids to flow through the tube. A plurality of holes 116 extend through tube 110 so that fluids may flow into or out of tube 110 through the holes. Tube 110 is of sufficient length so that it extends from the outside of the patient into the kidney, through the ureter and into the bladder.


First pigtail curl 160 and second pigtail curl 170 serve the purpose of retaining or keeping tube 110 in the proper position within the patient. First pigtail curl 160 is located near first end 112 and second pigtail curl 170 is near second end 114, so that first pigtail curl 160 lies within the collecting system of the kidney and second pigtail curl 170 lies within the bladder. Each curl serves as a retention feature and ensures tube 110 will not move out of the ureter, because each curl is too large to pass through the ureter. Second pigtail curl 170 enters the ureter in a straight position, but the material of tube 110 at the section of second pigtail curl room to bend, or once it has exited the ureter.


First pigtail curl 170 is such that it will bend into the curl position shown in FIG. 1 after the tube has curl enters the kidney in the straight position as well, and may also bend into the curl position once in place. However, to help first pigtail curl bend to the proper position, a string 180 may be pulled through a hole of the plurality of holes 116, as shown in FIG. 2, and the string may be manually pulled on both ends 182, 184 until first pigtail curl is set in place. Thereafter, string 180 may be manually removed by pulling one of ends 182, 184. String 180 may be a suture. Alternatively, string 180 may be a number of other materials.


Locking mechanism 140 may be a number of locking mechanisms currently used in the art. Locking mechanism closes off detachable portion 130 of tube 110, and may be manually opened and removed to access any of detachable portion 130, inner tube 150, or tube 110.


Detachable portion 130 may be made from the same material as tube 110. Detachable portion 130 may be flush with tube 110 at marker 190. Detachable portion 130 comprises a hollow section within which inner tube 150 may slide through. Inner tube may extend through a portion of tube 110, as shown in FIG. 2. Inner tube 150 comprises a hollow interior to allow for fluid to flow through the interior of inner tube 150. Fluid is exchanged between tube 110 and inner tube 150 through the hollow interior of inner tube 150. Tube 110 also comprises at least a portion of a hollow section within which tube portion 150 may slide through. In some example embodiments, the hollow portions of both detachable portion 130 and tube 110 may be sized such that when inner tube portion 150 is inside the hollow portions of the detachable portion 130 and tube 110, there is a friction seal between the exterior surface of tube portion 150 and the walls of the hollow portions. However, tube portion 150 may be attached to tube 110 in a number of other ways. For example, in an alternative embodiment, inner tube 150 may comprise threads on its exterior surface that correspond to threads along the walls of the hollow interior of tube 110, and thus to remove inner tube 150 from tube 110, inner tube 150 must be unscrewed from tube 110. In another alternative embodiment, detachable portion 130 may comprise a smaller circumference than tube 110 such that detachable portion 130 may also fit within the hollow portion of tube 110, for example 2 or 3 mm into tube 110. Thus when inner tube 150 is in place within both tube 110 and detachable portion 130, inner tube 150 pushes outward on detachable portion 130, which in turn presses on tube 110, resulting in a tighter fit. In this embodiment, detachable portion 130 may still be manually removed from tube 110 after the removal of inner tube 150 from tube 110.


Detachable portion 130 may be manufactured as part of catheter 100. When attached to catheter 100 and in place inside a patient, detachable portion 130 extends from the center of the kidney to an exit in the back of the patient, ending with locking mechanism 140, which is located outside the patient's body.


In another example embodiment, an inner tube portion 250 and a wire 255 may extend through both detachable portion 230 and the tube 210, as shown in FIG. 3. In this embodiment, inner tube portion 250 comprises a hollow interior or lumen 252 to allow for fluid to flow therethrough. Thus, fluid is exchanged between tube 210 and inner tube portion 250 through the hollow interior of inner tube portion 250. Tube 210 also comprises at least a portion of a hollow section within which tube portion 250 may slide through.


Detachable portion 230 may be manufactured as part of catheter 200. When attached to catheter 200 and in place inside a patient, detachable portion 230 extends from the center of the kidney to an exit in the back of the patient, ending with locking mechanism 240, which is located outside the patient's body.



FIG. 4a shows a detailed view of the catheter 200 of FIG. 3. Wire 255 is shown to extend through lumen 252 of inner tube 250. Wire 255 may extend from locking mechanism 240 in the distal direction through the entire length of lumen 252 of inner tube 250, in some example embodiments. In other example embodiments, however, wire 255 may only extend partially through lumen 252 of inner tube 250. Wire 255 may comprise a portion 256 that extends through and over the exterior of tube 210, at a region where tube 210 overlaps the inner tube 250, thereby affixing tube 210 and inner tube 250. The portion 256 may comprise a first angled section 257 that extends from within lumen 252 of inner tube 250, through the wall of tube 210 and an outer surface 202 of tube 210, a generally flattened section 258 that extends above outer surface 202 of tube 210, and a second angled section 259 that extends from generally flattened section 258, through the wall of tube 210 back into lumen 252 of inner tube 250.


The wire 255 may be affixed to and then removed at the locking mechanism 240 to disconnect the distal section of inner tube 250 from tube 210, rendering the catheter 200 a stent, as will be described with further detail below. The locking mechanism may comprise a luer lock, for example. Other locking mechanisms may also be envisioned. Such a locking mechanism may be affixed via any of a number of bonding or fastening methods.


Wire 255 may comprise a material that has sufficient tensile strength to hold inner tube 250 and tube 210 together, such as a metallic composite material. Example metallic composite materials that may be used are stainless steel, Elgiloy, a nickel cobalt alloy (e.g., MP35N), or a nickel titanium alloy (e.g., Nitinol), for example.


To connect the detachable portion 230 to tube 210, wire 255 may be sent through inner tube 250, which may contain one or more lumens.


In an alternative embodiment shown in FIG. 4b, instead of wire 255 traveling through the wall of tube 210 and extending beyond exterior 202 of tube 210 to affix the inner tube 250 within the tube 210, wire 255 may continue over a separate wire segment 254 which is normal to wire 255 and within lumen of tube 210. The separate wire segment 254 may be fused into the wall of tube 210 while providing a small area for passage of wire 255 and a large area for passage for inner tube 252. The wire 255 may continue its path over the separate wire segment 254, remaining entirely within the lumen of tube 210, and completing second angled section 259 to return into lumen 252 of inner tube 250.



FIGS. 5a-5b show detailed top and side views of a wire 350 within a tube 310, in accordance with an example embodiment. The tube 310 may take the same form as or may be similar in form to the tube 110 or 210 described with reference to FIGS. 1-4. A detachable portion 330 and an inner tube 350 are also shown, and may take the same form as or may be similar in form to the detachable portion 130 or 230 and the inner tube 150 or 250 described with reference to FIGS. 1-4. In the embodiment shown in FIGS. 5a-5b, a wire 355, comprising a metal band, may be used to removably attach the detachable portion 330 to the tube 310. An engagement portion 356 of the wire 355 is shown to engage into an interior wall 305 of the catheter 300. The engagement portion 356 may comprise a bump, hill, or other pronounced surface extending above the surface of the remaining wire 355.



FIG. 6 shows a detailed cross-sectional side view of a wire 450 within a catheter 400, in accordance with an example embodiment. The catheter 400 may take the same form as or may be similar in form to catheter 100 or 200 described with reference to FIGS. 1-4. A detachable portion 430 is also shown, and may take the same the detachable portion 130 or 230 described with reference to FIGS. 1-4.


An inner tube 450 may comprise two lumens, first lumen 451 and second lumen 452. First lumen 451 may comprise a wall to separate first lumen 451 from second lumen 452. A wire 455, which may take the form of either wire 255 or wire 355, may run through first lumen 451 and thus be isolated within lumen 451 so as not to interfere with second lumen 452. Second lumen 452 may serve as a wire guide or stent straightening lumen. The dual lumen feature of inner tube 450 permits the use of an isolated access pathway (second lumen 452) to be used for device tooling such as a wire guide or stent straightener without risk of disrupting wire 455 located within lumen 451. First lumen 451 provides a protective safeguard against dislodgement of wire 455 during implantation of the catheter within patient and during the corresponding exchange of catheter tooling during intervention. Fluid may be exchanged between catheter 400 and inner tube 450 via both first lumen 451 and second lumen 452.



FIG. 7 shows a detailed cross-sectional side view of an example detachable portion 530 of a catheter 500, according to an example embodiment. The catheter 500 may take the same form as or may be similar in form to catheter 100 or 200 described with reference to FIGS. 1-4. The catheter 500 may comprise a tube 510, which may take the same form as or may be similar in form to tube 110 or 210 described with reference to FIGS. 1-4.


Detachable portion 530 may comprise a first tube portion 532, a second tube portion 534, and a transition 536 from the first tube portion 532 to the second tube portion 534. Transition 536 may take the form of a step and may comprise about a 90 degree transition. A lumen 533 may extend through both the first tube portion 532 and the second tube portion 534 as shown, and may comprise the same diameter through both portions. Transition 536 may mate with or abut an end 505 of catheter 500. Second tube portion 534 comprises a smaller diameter than the first tube portion 532, and is sized and shaped to fit within the lumen of the catheter 500. Such a design for detachable portion 530 renders having an additional inner tube, such as inner tubes 150 and 250, for example, unnecessary.



FIG. 8 shows a perspective view of a stent 200 that remains after the detachable portion has been removed. Stent 200 comprises the same tube 110 as catheter 100, with first pigtail curl 160 and second pigtail curl 170 untouched within the body of the patient. Detachable portion 130, inner tube 150, and locking mechanism 140 have been removed. A new end 210 is at marker 190.


In operation, the right or left flank of the patient is sterilely prepared depending upon which kidney is to be accessed. Intravenous sedation is used. A small bore needle is used to puncture the collecting system of the kidney and contrast is injected allowing the complete visualization of the entire collecting system. The central portion is initially punctured with a small needle, and then a larger needle is used to puncture a smaller but safer area of the collecting system. A guidewire is threaded into the collecting system of the kidney and a pigtail drain, or nephrostomy catheter, is placed, sutured to the back, and hooked up to a bag for external drainage.


Once the urine has cleared from bleeding, the patient is brought back and a wire is inserted through the catheter into the kidney and the catheter is removed. The wire is threaded through the ureter into the bladder (across the stricture) and catheter 100 is placed. Pigtail curls 160, 170 are curled to their proper position. The catheter typically stays in the patient for 7-10 days, at which time the patient is brought back.


At this point, if the physician desires to exchange the catheter 100 for a stent 200, the physician will unlock locking mechanism 140, and will remove the locking mechanism to access inner tube 150. The physician will then manually pull inner tube 150 through the hollow portion of tube 110 toward first end 112, until inner tube 150 has been pulled past marker 190 and is no longer within the hollow portion of tube 110.


In another example embodiment, wherein a wire is used, such as described with reference to FIGS. 3-7, the physician will first release the locking mechanism maintaining connection with a wire, such as wire 255, 355, 455, or 555. The wire may be released using a method such as unscrewing a cap, for example. In such an example embodiment, the unscrewed cap (which has been attached to the wire at the proximal luer hub) disengages the wire from the catheter (e.g., catheters 310 and 400) by pulling the cap away from the hub and fully withdrawing the wire from the inner tube (e.g., inner tubes 250, 350, 450). Once the wire has been removed, the detachable portion (e.g., detachable portions 330 and 530) and the inner tube may now be fully withdrawn from the patient's body, converting the catheter into a stent (e.g., stent 200).


Once inner tube 150 has been removed from tube 110, detachable portion 130 is no longer attached to tube 110 and both detachable portion 130 and inner tube 150 may be removed from the patient's body. Once detachable portion 130 and inner tube 150 are removed, catheter 100 becomes a stent 200, as shown in FIG. 3. This is same type of stent that would typically be placed by the urologist working through the bladder. Stent 200 now comprises a new end 210 that is located at marker 190.


An example of when the convertible nephroureteral catheter may be used is a situation in which a patient has a blockage of the ureter and presents with hydronephrosis (dilation of the kidney's collecting system) and hydroureter (dilation of the ureter). The patient has a device inserted through the flank, into the collecting system, and through the ureter into the bladder. The device will be left open to external drainage until the urine clears from infection or bleeding. When the urine has cleared, the external portion of the convertible nephroureteral catheter 100 will be detached, converting the catheter into an internal stent. From this point forward, the stent will drain urine directly from the kidney to the bladder. The internal stent will remain in place until it is ready to be removed or replaced.


Another example of use is when a patient recently passed a kidney stone and the ureter is temporarily inflamed and blocked. The convertible nephroureteral catheter is inserted in the same manner described above. In this situation, however, the catheter is in place temporarily until the inflammation improves; once this is confirmed, the entire catheter is removed by pulling it out of the flank with contrast injection under fluoroscopy. In this situation the detachable portion is not detached. However, the catheter may also be left in place as an internal stent, and the detachable portion removed, depending on the clinical need.


Another example of use is when a patient has leakage from the ureter due to trauma, instrumentation, stone removal, cancer, or another reason, and internal and external urine diversion is necessary. In this case, convertible nephroureteral catheter 100 is placed in the patient and urine is allowed to drain externally. When there is improvement in the leakage and the catheter is converted to an internal stent by removing detachable portion 130, internal urine diversion is allowed for a longer period of time. The stent 500 will be removed at a later date after the leak is resolved.


It will thus be seen that certain changes may be made in the above constructions without departing from the spirit and scope of the invention. It is intended that all matter contained in the above description or shown in the accompanying drawings shall be interpreted as illustrative and not in a limiting sense.

Claims
  • 1. A method for converting a catheter into a stent comprising: providing a catheter having a tube comprising a distal end, a proximal end, a first retention feature near the distal end and a second retention feature near the proximal end, and a detachable portion comprising a distal end and a proximal end,wherein the detachable portion is in fluid communication with and is removably attachable to the tube, the distal end of the detachable portion being removably attachable to the proximal end of the tube, the distal end of the detachable portion having an outer diameter that is substantially the same as an outer diameter of the proximal end of the tube, and wherein the tube and the detachable portion together form a convertible catheter;percutaneously implanting the convertible catheter into a first bodily cavity so that the first retention feature is curled and disposed in a second bodily cavity, the second retention feature is curled and disposed in the first bodily cavity, and the detachable portion extends external to a patient, wherein the first retention feature and second retention feature are each curled while the detachable portion is coupled to the tube;proximally pulling a string releasably coupled to the tube adjacent the second retention feature to curl the second retention feature;allowing fluid to drain through the implanted convertible catheter;removing the detachable portion from the catheter to convert the catheter into an internal stent, wherein an inner tube extends through at least a portion of both the tube and the detachable portion and comprises at least one lumen,wherein a wire extends through at least a portion of the at least one lumen and couples the detachable portion to the tube via an extension extending through a wall of the tube, andwherein removing the detachable portion from the catheter to convert the catheter into the internal stent comprises proximally retracting the wire to disconnect the detachable portion from the tube; andretaining the internal stent in the first bodily cavity and the second bodily cavity.
  • 2. The method of claim 1, further comprising: providing a locking mechanism at the proximal end of the detachable portion, wherein the locking mechanism is configured to open and close; andclosing the locking mechanism to prevent access to an interior of the detachable portion.
  • 3. The method of claim 1, further comprising: positioning the catheter in the patient by creating an incision in the patient at a surgical site and inserting the catheter through the incision.
  • 4. The method of claim 3, wherein the surgical site is a flank of the patient to access one or more of the first or second bodily cavities via the flank.
  • 5. The method of claim 3, further comprising: attaching the catheter to tubing exterior to the patient.
  • 6. The method of claim 3, wherein removing the detachable portion comprises removing the detachable portion from the patient.
  • 7. The method of claim 1, wherein the method is used to provide or monitor treatment for a disorder of one or more of the first or second bodily cavities.
  • 8. The method of claim 1, wherein the convertible catheter is percutaneously implanted into the first bodily cavity so that at least a portion of the detachable portion is within the patient, and wherein removing the detachable portion from the catheter comprises withdrawing the detachable portion from the patient.
  • 9. The method of claim 1, wherein the implanted convertible catheter is retained in the second bodily cavity for 7-10 days prior to removing the detachable portion from the catheter to convert the catheter into the internal stent.
  • 10. The method of claim 1, wherein the first bodily cavity is a kidney.
  • 11. The method of claim 10, wherein the second bodily cavity is a bladder, and wherein the convertible catheter comprises a nephroureteral catheter.
  • 12. A method for converting a catheter into a stent comprising: providing a catheter having a tube comprising a distal end, a proximal end, a first retention feature near the distal end and a second retention feature near the proximal end, and a detachable portion,wherein the detachable portion is in fluid communication with and is removably attachable to the tube at a junction, wherein an outer diameter of the detachable portion and an outer diameter of the tube at the junction are substantially the same, and wherein the tube and the detachable portion together form a convertible catheter;percutaneously implanting the convertible catheter into a first bodily cavity so that the first retention feature is curled and disposed in a second bodily cavity, the second retention feature is curled and disposed in the first bodily cavity, and the detachable portion extends external to a patient, wherein the first retention feature and second retention feature are each curled while the detachable portion is coupled to the tube;proximally pulling a string releasably coupled to the tube adjacent the second retention feature to curl the second retention feature;allowing fluid to drain through the implanted convertible catheter;removing the detachable portion from the catheter to convert the catheter into an internal stent, wherein an inner tube extends through at least a portion of both the tube and the detachable portion and comprises at least one lumen,wherein a wire extends through at least a portion of the at least one lumen and couples the detachable portion to the tube via an extension extending through a wall of the tube, andwherein removing the detachable portion from the catheter to convert the catheter into the internal stent comprises proximally retracting the wire to disconnect the detachable portion from the tube; andretaining the internal stent in the first bodily cavity and the second bodily cavity.
  • 13. The method of claim 12, further comprising: providing a locking mechanism at a first end of the detachable portion, wherein the locking mechanism is configured to open and close; andclosing the locking mechanism to prevent access to an interior of the detachable portion.
  • 14. The method of claim 12, further comprising: positioning the catheter in the patient by creating an incision in the patient at a surgical site and inserting the catheter through the incision.
  • 15. The method of claim 14, wherein the surgical site is a flank of the patient to access one or more of the first or second bodily cavities via the flank.
  • 16. The method of claim 14, further comprising: attaching the catheter to tubing exterior to the patient.
  • 17. The method of claim 12, wherein removing the detachable portion comprises removing the detachable portion from the patient.
  • 18. The method of claim 12, wherein the convertible catheter is percutaneously implanted into the first bodily cavity so that at least a portion of the detachable portion is within the patient, and wherein removing the detachable portion from the catheter comprises withdrawing the detachable portion from the patient.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/175,436, filed Jun. 7, 2016 (now issued as U.S. Pat. No. 10,695,161 on Jun. 30, 2020), which is a divisional of U.S. patent application Ser. No. 14/159,221 (now issued as U.S. Pat. No. 9,387,312 on Jul. 12, 2016), filed Jan. 20, 2014, which is a continuation-in-part of U.S. patent application Ser. No. 12/559,946 (now issued as U.S. Pat. No. 8,657,884 on Feb. 25, 2014), filed Sep. 15, 2009, which claims the benefit of U.S. Provisional Application Ser. No. 61/096,902, filed Sep. 15, 2008, the contents of all of which are fully incorporated herein by reference.

US Referenced Citations (147)
Number Name Date Kind
818817 Leva Apr 1906 A
3996938 Clark, III Dec 1976 A
4350161 Davis, Jr. Sep 1982 A
4790810 Pugh, Jr. et al. Dec 1988 A
4813925 Anderson, Jr. Mar 1989 A
4830003 Wolff et al. May 1989 A
4913683 Gregory Apr 1990 A
4957479 Roemer Sep 1990 A
5002560 Machold et al. Mar 1991 A
5019090 Pinchuk May 1991 A
5071407 Termin et al. Dec 1991 A
5122136 Guglielmi et al. Jun 1992 A
5221253 Coll Jun 1993 A
5250069 Nobuyoshi et al. Oct 1993 A
5259847 Trambert Nov 1993 A
5282784 Willard Feb 1994 A
5354263 Coll Oct 1994 A
5364340 Coll Nov 1994 A
5456667 Ham et al. Oct 1995 A
5507732 McClure et al. Apr 1996 A
5507751 Goode et al. Apr 1996 A
5599291 Balbierz et al. Feb 1997 A
5643254 Scheldrup et al. Jul 1997 A
5653684 Laptewicz et al. Aug 1997 A
5846251 Hart Dec 1998 A
5876417 Devonec et al. Mar 1999 A
5921952 Desmond, III et al. Jul 1999 A
5964771 Beyar Oct 1999 A
6074339 Gambale et al. Jun 2000 A
6196996 Teirstein Mar 2001 B1
6248100 De et al. Jun 2001 B1
6264624 Desmond, III et al. Jul 2001 B1
6319287 Frimberger Nov 2001 B1
6562024 Toledo et al. May 2003 B2
6569150 Teague et al. May 2003 B2
6576008 Devonec et al. Jun 2003 B2
6629981 Bui et al. Oct 2003 B2
6673106 Mitelberg et al. Jan 2004 B2
6676651 Haacke et al. Jan 2004 B2
6913625 Segura et al. Jul 2005 B2
6929664 Kolb et al. Aug 2005 B2
6949125 Robertson Sep 2005 B2
6991614 McWeeney et al. Jan 2006 B2
7044980 Hammond et al. May 2006 B2
7044981 Liu et al. May 2006 B2
7169139 Teague et al. Jan 2007 B2
7217250 Kolb et al. May 2007 B2
7367987 Balgobin et al. May 2008 B2
7371252 Balgobin et al. May 2008 B2
7377932 Mitelberg et al. May 2008 B2
7550002 Goto et al. Jun 2009 B2
7566316 McGuckin, Jr. et al. Jul 2009 B2
7722604 Brown, III et al. May 2010 B2
7731676 Maeda Jun 2010 B2
7811305 Balgobin et al. Oct 2010 B2
7824367 Accisano, III Nov 2010 B2
7901444 Slazas Mar 2011 B2
7901704 Richard Mar 2011 B2
7993329 Howell et al. Aug 2011 B2
8007540 Robertson Aug 2011 B2
8021434 Segura et al. Sep 2011 B2
8034094 Aoba et al. Oct 2011 B2
8070825 Devonec Dec 2011 B2
8298276 Ozawa et al. Oct 2012 B2
8333000 Huang et al. Dec 2012 B2
8333796 Tompkins et al. Dec 2012 B2
8603185 Shah et al. Dec 2013 B2
8657884 Smouse Feb 2014 B2
8676349 Stalker et al. Mar 2014 B2
8702784 Weisman et al. Apr 2014 B2
8753303 Weisman et al. Jun 2014 B2
8771335 Griego et al. Jul 2014 B2
8961518 Taylor et al. Feb 2015 B2
8961581 Hollett et al. Feb 2015 B2
8979824 Amos et al. Mar 2015 B2
8986364 Okuma Mar 2015 B2
9026229 Stalker et al. May 2015 B2
9186151 Tompkins et al. Nov 2015 B2
9265637 Weisman et al. Feb 2016 B2
9308359 Ward Apr 2016 B2
9314359 Windheuser et al. Apr 2016 B2
9387312 Smouse Jul 2016 B2
9510962 Aoba et al. Dec 2016 B2
9517120 Devonec et al. Dec 2016 B2
9597207 Weisman et al. Mar 2017 B2
9956100 Smouse et al. May 2018 B2
20030069533 Kakutani et al. Apr 2003 A1
20030163204 Rix Aug 2003 A1
20030191450 Teague et al. Oct 2003 A1
20030195456 Robertson Oct 2003 A1
20040073283 Ewers Apr 2004 A1
20040098105 Stinson et al. May 2004 A1
20040181186 Gellman et al. Sep 2004 A1
20040249343 Cioanta Dec 2004 A1
20050085892 Goto et al. Apr 2005 A1
20070078446 Lavelle Apr 2007 A1
20070112420 Laduca May 2007 A1
20070233223 Styrc et al. Oct 2007 A1
20070276466 Lavelle et al. Nov 2007 A1
20080109059 Gordon et al. May 2008 A1
20080140101 Carley et al. Jun 2008 A1
20080221554 O'Connor et al. Sep 2008 A1
20090048654 Chmura et al. Feb 2009 A1
20090088833 Soetermans Apr 2009 A1
20090099640 Weng Apr 2009 A1
20090105719 Honey et al. Apr 2009 A1
20090248169 Li Oct 2009 A1
20090312829 Aoba et al. Dec 2009 A1
20100070047 Smouse Mar 2010 A1
20100185271 Zhang Jul 2010 A1
20100268201 Tieu et al. Oct 2010 A1
20110009950 Grandfield et al. Jan 2011 A1
20110077622 Weisman et al. Mar 2011 A1
20110130821 Styrc Jun 2011 A1
20110190862 Bashiri et al. Aug 2011 A1
20110196410 Besselink et al. Aug 2011 A1
20110196507 St. Pierre Aug 2011 A1
20110282249 Tsoref et al. Nov 2011 A1
20110282429 Shin et al. Nov 2011 A1
20110288624 Roeder et al. Nov 2011 A1
20110313404 Amos et al. Dec 2011 A1
20120041538 White et al. Feb 2012 A1
20120095567 Weisman et al. Apr 2012 A1
20120203325 Weisman et al. Aug 2012 A1
20120330397 Harrison et al. Dec 2012 A1
20130110042 Humphreys et al. May 2013 A1
20130254751 Howard Sep 2013 A1
20140114431 Yamagata Apr 2014 A1
20140135941 Smouse et al. May 2014 A1
20140172065 Lavelle et al. Jun 2014 A1
20140194970 Chobotov Jul 2014 A1
20140200462 Stalker et al. Jul 2014 A1
20140309721 Griego et al. Oct 2014 A1
20150005864 Okuma Jan 2015 A1
20150073525 Aoba et al. Mar 2015 A1
20150157480 Amos et al. Jun 2015 A1
20150223953 Pendleton et al. Aug 2015 A1
20160015509 Mcdonough Jan 2016 A1
20160045347 Smouse et al. Feb 2016 A1
20160120675 Weisman et al. May 2016 A1
20160135941 Binmoeller et al. May 2016 A1
20160151615 Overtoom Jun 2016 A1
20160184123 Windheuser et al. Jun 2016 A1
20160287372 Smouse et al. Oct 2016 A1
20160361167 Tuval et al. Dec 2016 A1
20180325709 Tatalovich et al. Nov 2018 A1
20210007870 Smouse et al. Jan 2021 A1
Foreign Referenced Citations (24)
Number Date Country
2128148 Mar 1993 CN
2408894 Dec 2000 CN
201624817 Nov 2010 CN
102548505 Jul 2012 CN
102579171 Jul 2012 CN
102596083 Jul 2012 CN
202537720 Nov 2012 CN
202637201 Jan 2013 CN
103211671 Jul 2013 CN
103876872 Jun 2014 CN
103961194 Aug 2014 CN
2002071765 Mar 2002 JP
2003530165 Oct 2003 JP
2009297502 Dec 2009 JP
2012239803 Dec 2012 JP
201507357 Apr 2015 JP
1988005317 Jul 1988 WO
WO-8805317 Jul 1988 WO
199611721 Apr 1996 WO
2013003450 Jan 2013 WO
WO-201 5108609 Jul 2015 WO
WO-201 6025434 Feb 2016 WO
WO-2016042150 Mar 2016 WO
WO-2018156650 Aug 2018 WO
Non-Patent Literature Citations (30)
Entry
Co-pending U.S. Appl. No. 15/901,833, filed Feb. 21, 2018.
Co-pending U.S. Appl. No. 15/936,856, filed Mar. 27, 2018.
U.S. Appl. No. 14/823,243 Notice of Allowance dated Mar. 26, 2018.
Office Action dated Sep. 9, 2019 for U.S. Appl. No. 15/175,436.
European Search Report and Search Opinion dated Sep. 7, 2017 for European Patent Application No. 14878890.4.
European search report and search opinion dated Dec. 22, 2017 for EP Application No. 15831895.6.
International search report and written opinion dated Jan. 7, 2016 for PCT Application No. PCT/US15/44580.
International search report and written opinion dated Mar. 25, 2015 for PCT Application No. PCT/US2014/063758.
Notice of allowance dated Jan. 16, 2018 for U.S. Appl. No. 14/823,243.
Notice of allowance dated May 13, 2016 for U.S. Appl. No. 14/159,221.
Notice of allowance dated Oct. 9, 2013 for U.S. Appl. No. 12/559,946.
Office action dated Jan. 3, 2012 for U.S. Appl. No. 12/559,946.
Office action dated Feb. 26, 2016 for U.S. Appl. No. 14/159,221.
Office action dated Apr. 18, 2017 for U.S. Appl. No. 14/823,243.
Office Action dated Aug. 31, 2017 for U.S. Appl. No. 14/823,243.
Office action dated Oct. 7, 2015 for U.S. Appl. No. 14/159,221.
Office action dated Oct. 24, 2012 for U.S. Appl. No. 12/559,946.
“International Search Report and Written Opinion dated Jun. 15, 2018 for International PCT Patent Application No. PCT/US18/19045”.
Office Action dated Dec. 31, 2019 for U.S. Appl. No. 15/175,436.
European Search Report dated May 19, 2020 for EP15831895.6.
Notice of Allowance dated Apr. 20, 2020 for U.S. Appl. No. 15/936,856.
Notice of Allowance dated Apr. 27, 2020 for U.S. Appl. No. 15/175,436.
Office Action dated Jan. 10, 2020 for U.S. Appl. No. 15/936,856.
Office Action dated Feb. 12, 2020 for U.S. Appl. No. 15/901,833.
Office Action dated Sep. 19, 2019 for U.S. Appl. No. 15/901,833.
European Search Report dated Dec. 22, 2020 for EP18758123.6.
Office Action dated Sep. 4, 2020 for U.S. Appl. No. 15/901,833.
Office Action dated Feb. 5, 2021 for U.S. Appl. No. 15/901,833.
Office Action dated May 28, 2021 for U.S. Appl. No. 15/901,833.
International Search Report and Written Opinion dated Jul. 26, 2021 for PCT/US2021/026886.
Related Publications (1)
Number Date Country
20180235744 A1 Aug 2018 US
Provisional Applications (1)
Number Date Country
61096902 Sep 2008 US
Divisions (1)
Number Date Country
Parent 14159221 Jan 2014 US
Child 15175436 US
Continuations (1)
Number Date Country
Parent 15175436 Jun 2016 US
Child 15958406 US
Continuation in Parts (1)
Number Date Country
Parent 12559946 Sep 2009 US
Child 14159221 US